Functional preservation in patients with renal cortical tumors: The rationale for partial nephrectomy

Current Urology Reports

Volumn 9, Issue 1, 2008, Pages 15-21

  Russo, Paul ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER SURGERY; CHRONIC KIDNEY DISEASE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY CORTEX; KIDNEY TUMOR; METASTASIS; PARTIAL NEPHRECTOMY; REVIEW; RISK ASSESSMENT; RISK FACTOR;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY NEOPLASMS; NEPHRECTOMY; RISK FACTORS;

EID: 38349053343     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-008-0005-4     Document Type: Review

References (51)

1. Linehan WM, Walther MM, Zbar B: The genetic basis of cancer of the kidney. J Urol 2003, 170:2163-2172.
2. Russo P, Snyder M, Vickers A, et al.: Cytoreductive nephrectomy and nephrectomy/complete metastasectomy for renal cancer. TSW Urology 2007, 2:42-52.
3. Flanigan RC, Salmon SE, Blumenstein BA, et al.: Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 2001, 345:1655-1659.
4. Russo P: Renal cell carcinoma: presentation, staging, and surgical treatment. Semin Oncol 2000, 27:160-176.
5. McKiernan JM, Yossepowitch O, Kattan MW, et al.: PN for renal cortical tumors: pathological findings and impact on outcome. Urology 2002, 60:1003-1009.
6. Snyder ME, Bach A, Kattan MW, et al.: Incidence of benign lesions for clinically localized renal masses < 7 cm in radiological diameter: Influence of gender. J Urol 2006, 176:2391-2396.
7. Dechet CB, Zincke H, Sebo TJ, et al.: Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults. J Urol 2003, 169:71-74.
8. Divgi C, Pandit-Taskar N, Jungbluth AA, et al.: Preoperative characterization of clear cell renal carcinoma using iodine-124 labeled antibody chimeric G250 (1241-cG250) and positron emission tomography (PET): phase 1 surgical validation in patients with renal masses. Lancet Oncol 2007, 8:304-310. This study describes a novel approach to diagnosis clear cell renal cell carcinoma (RCC) using a specific antibody, G250, positron emission tomography (PET) scan.
9. Russo P, Goetzl M, Simmons R, et al.: Partial nephrectomy: the rationale for expanding the indications. Ann Surg Oncol 2002, 9:680-687.
10. Lee CT, Katz J, Shi W, et al.: Surgical management of renal tumors of 4 cm or less in a contemporary cohort. J Urol 2000, 163:730-736.
11. Leibovich BC, Blute ML, Cheville JC, et al.: Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm resulting in outcome similar to radical nephrectomy. J Urol 2004, 171:1066-1070. This study confirms the oncologic equivalency of PN and RN for tumors 4 to 7 cm.
12. Gilbert BR, Russo P, Zirinsky K, et al.: Intraoperative sonography. Application in renal cell carcinoma. J Urol 1988, 139:582-584.
13. Stephanson A, Hakimian A, Snyder ME, Russo P: Complications of radical and PN in a large contemporary cohort. J Urol 2004, 171:130-134.
14. Richstone L, Scherr DS, Reuter VR, et al.: Multifocal renal cortical tumors: frequency, associated clinicopathological features, and impact on survival. J Urol 2004, 171:615-620.
15. Tismit MO, Razin JP, Thionunn N, et al.: Prospective study of the safety margins in partial nephrectomy: intraoperative assessment and contribution of frozen section analysis. Urology 2006, 67:923-926.
16. Schachter LR, Bach AM, Snyder ME, et al.: The impact of tumor location on histological subtype of renal cortical tumors. BJU Int 2006, 98:63-66.
17. Dash A, Vickers AJ, Schachter LR, et al.: Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4-7 cm. BJU Int 2006, 97:939-945. This study confirms the oncologic equivalency of PN and RN for clear cell tumors of 4 to 7 cm.
18. Patel MI, Simmons R, Kattan MW, et al.: Long term follow up of bilateral sporadic renal tumors. Urology 2003, 61:921-925.
19. Kattan MW, Reuter V, Motzer RJ, et al.: A postoperative prognostic nomogram for renal cell. J Urol 2001, 166:63-67.
20. Najaraian JS, Chavers BM, McHugh LE, Matas AJ: 20 years or more of follow-up of living kidney donors. Lancet 1992, 340:807-810.
21. Fehrman-Ekholm I, Duner F, Brink B, et al.: No evidence of loss of kidney function in living kidney donors from cross sectional follow up. Transplantation 2001, 72:444-449.
22. Goldfarb DA, Matin SF, Braun WE, et al.: Renal outcome 25 years after donor nephrectomy. J Urol 2001, 166:2043-2047.
23. Kaplan C, Pasternack B, Shah H, et al.: Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 1975, 80:227-234.
24. Bijol V, Mendez GP, Hurwitz S, et al.: Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens. Am J Surg Pathol 2006, 30:575-584. This study describes the histopathologic basis of CKD observed in apparently normal patients undergoing kidney tumor surgery.
25. Renal Data Systems. 2005 Annual Data Report: Atlas of End-stage Renal Disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2005.
26. Stevens LA, Coresh J, Green T, Levey AS: Assessing kidney function: measured and estimated glomerular filtration rate. N Engl J Med 2006, 354:2473-2483. This article reviews the importance of assessing renal function using eGFR.
27. Sarnak M, Leavey AS, Schoolwerth AC, et al.: Kidney disease as a risk factor for the development of cardiovascular disease: a statement from the American Heart Association Council on Kidney in Cardiovascular Disease. High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003, 108:2154-2169.
28. Chobanian AV, Bakris GL, Black HR, et al.: The Seventh Report of the Joint National Committee on TN Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
29. Kidney Disease Outcome Quality Initiative. K/DOQI clinical guideline for chronic kidney disease evaluation, classification, stratification. Am J Kidney Dis 2002, 51:5246.
30. Ritz E, McClellan WW: Overview: increased cardiovascular risk in patients with minor renal dysfunction: an emerging issue with far-reaching consequences. J Am Soc Nephrol 2004, 15:513-516.
31. Shlipak MG, Fried LF, Cushman M, et al.: Cardiovascular mortality risk in chronic kidney disease. JAMA 2005, 293:1737-1745.
32. Poggio ED, Wang X, Greene T, et al.: Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 2005, 16:459-466.
33. Levey AS, Coresh J, Greene T, et al.: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006, 145:247-254.
34. Go AS, Chertow GM, Fan D, et al.: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351:1296-1305. This study correlates a decline in eGFR with cardiovascular disease, hospitalization, and death in a population-based study of over 1 million patients.
35. Foley RN, Wang C, Collins AJ: Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES 3 study. Mayo Clin Proc 2005, 80:1270-1277.
36. Lau WK, Blute ML, Weaver AL, et al.: Matched comparison of radical nephrectomy vs. nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contra lateral kidney. Mayo Clinic Proc 2000, 75:1236-1242.
37. McKiernan J, Simmons R, Katz J, Russo P: Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 2002, 59:816-820.
38. Sorbellini M, Kattan MW, Snyder ME, et al.: Prognostic nomogram for renal insufficiency after radical or partial nephrectomy. J Urol 2006, 176:472-476.
39. 2, indicative of stage 3 CKD. This study also demonstrates the adverse impact of RN compared with PN on eGFR.
40. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2007. CA Cancer J Clin 2007, 57:43.
41. Hollenback BK, Tash DA, Miller DC, et al.: National utilization trends of PN for renal cell carcinoma: a case of underutilization? Urology 2006, 67:254-259.
42. Miller DC, Hollingsworth JM, Hafez KS, et al.: PN for small renal masses. An emerging quality of care concern? J Urol 2006, 175:853-857.
43. Nuttal M, Cathcart P, van der Meulen J, et al.: A description of radical nephrectomy practice and outcomes in England, 1995-2002. BJU Int 2005, 96:58-61.
44. Scherr DS, Ng C, Munver R, et al.: Practice patterns among urologic surgeons treating localized renal cell carcinoma in the laparoscopic age: technology vs. oncology. Urology 2003, 62:1007-1011.
45. Ramani AP, Desai MM, Steinberg AP, et al.: Complications of laparoscopic PN in 200 cases. J Urol 2005, 173:42-47.
46. Kim FJ, Rha KH, Hernandez F, et al.: Laparoscopic radical versus partial nephrectomy: assessment of complications. J Urol 2003, 170:408-411.
47. Gill IS, Kavoussi LR, Lane BR, et al.: Comparison of 1800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 2007, 178:41-46. This study compares LPN to OPN in a multi-institutional experience of 1800 patients. LPN is a challenging operation associated with post-operative complications and secondary procedures to address those complications.
48. Diblasio CJ, Snyder ME, Russo P: Mini-flank supra-eleventh incision for open partial or radical nephrectomy. BJU Int 2006, 97:149-156.
49. Gill IS, Remer EM, Hasan WA, et al.: Renal cryoablation: outcome at 3 years. J Urol 2005, 173:1903-1907.
50. Wehle MJ, Thiel DD, Petrou SP, et al.: Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy. Urology 2004, 64:49-52.
51. Volpe A, Jewett MA: The role of surveillance for small renal masses. Nat Clin Pract Urol 2007, 4:2-3.